Ethical Issues Related To BRCA Gene Testing in Orthodox Jewish Women

Persons exhibiting mutations in two tumor suppressor genes, BRCA1 and BRCA2, have a greatly increased risk of developing breast and/or ovarian cancer. The incidence of BRCA gene mutation is very high in Ashkenazi Jewish women of European descent, and many issues can arise, particularly for observant...

Description complète

Enregistré dans:  
Détails bibliographiques
Auteurs: Mor, Pnina (Auteur) ; Oberle, Kathleen (Auteur)
Type de support: Électronique Article
Langue:Anglais
Vérifier la disponibilité: HBZ Gateway
Journals Online & Print:
En cours de chargement...
Fernleihe:Fernleihe für die Fachinformationsdienste
Publié: Sage 2008
Dans: Nursing ethics
Année: 2008, Volume: 15, Numéro: 4, Pages: 512-522
Sujets non-standardisés:B ethics and genetics
B BRCA gene
B Orthodox Jewish women
B genetics testing
B healthy carriers
B Jewish ethics
Accès en ligne: Volltext (lizenzpflichtig)
Description
Résumé:Persons exhibiting mutations in two tumor suppressor genes, BRCA1 and BRCA2, have a greatly increased risk of developing breast and/or ovarian cancer. The incidence of BRCA gene mutation is very high in Ashkenazi Jewish women of European descent, and many issues can arise, particularly for observant Orthodox women, because of their genetic status. Their obligations under the Jewish code of ethics, referred to as Jewish law, with respect to the acceptability of various risk-reducing strategies, may be poorly understood. In this article the moral direction that Jewish law gives to women regarding testing, confidentiality, and other issues is explored. The intent is to broaden nurses' knowledge of how a particular religious tradition could impact on decision making around genetics testing, with the aim of enhancing their understanding of culturally sensitive ethical care.
ISSN:1477-0989
Contient:Enthalten in: Nursing ethics
Persistent identifiers:DOI: 10.1177/09697330080150041201